Surpassing state‐of‐the‐art glycopeptide analysis, we were able to assess subclass and allotype distributions, subclass‐specific glycosylation, CH3 domain glycosylation, and PTM profiles for total and ACPA IgG from paired samples of plasma and SF of RA patients. This evidence concerns the gene PRTN3 and rheumatoid arthritis.